Clinical Trial Data: Placebo-controlled studies with sufficient adverse event data were not available for the combination of 2,4-Dichlorobenzyl alcohol and amylmetacresol. Post Marketing Data: No adverse events were identified from the analysis of the dichlorobenzyl alcohol and amylmetacresol which warrants inclusion in this section.